| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK | GSK PLC | $117.64B | $58.54 | N/A | N/A | N/A | N/A | -5.19% | -16.48% | 39.93% | 10.70% | |||
| BMY | BRISTOL MYERS SQUIBB CO | $121.90B | $59.86 | $60.18 | 0.54% | Buy | 11 | -5.32% | 17.47% | 53.93% | 11.06% | |||
| LLY | ELI LILLY & CO | $979.46B | $1,038.27 | $1.17k | 12.79% | Strong Buy | 17 | 15.53% | 26.57% | 199.20% | 46.99% | |||
| SNY | SANOFI | $118.81B | $47.03 | $58.00 | 23.33% | Strong Buy | 1 | 2.02% | 31.49% | 16.32% | 9.14% | |||
| GRFS | GRIFOLS SA | $6.38B | $9.28 | $10.00 | 7.76% | Hold | 1 | 4.46% | 80.52% | 15.62% | 4.29% | |||
| AZN | ASTRAZENECA PLC | $317.01B | $204.52 | N/A | N/A | N/A | N/A | 7.00% | 25.79% | 45.88% | 19.57% | |||
| AMGN | AMGEN INC | $197.19B | $366.20 | $346.15 | -5.47% | Buy | 13 | 2.91% | 22.01% | 142.44% | 15.20% | |||
| ABBV | ABBVIE INC | $402.08B | $227.50 | $250.29 | 10.02% | Strong Buy | 14 | 9.55% | 137.95% | -1,295.13% | 25.55% | |||
| GILD | GILEAD SCIENCES INC | $188.35B | $151.81 | $151.50 | -0.20% | Strong Buy | 12 | 5.03% | 16.49% | 64.56% | 23.76% | |||
| MRK | MERCK & CO INC | $295.96B | $119.24 | $121.00 | 1.48% | Buy | 13 | 5.30% | 16.37% | 49.54% | 19.83% | |||
| AMRN | AMARIN CORP PLC | $308.98M | $14.86 | N/A | N/A | N/A | N/A | -9.80% | N/A | 101.68% | 70.72% | |||
| OGN | ORGANON & CO | $1.84B | $7.06 | $9.50 | 34.56% | Strong Sell | 3 | 1.15% | 30.56% | 108.68% | 7.27% | |||
| JNJ | JOHNSON & JOHNSON | $589.34B | $244.55 | $231.94 | -5.16% | Buy | 16 | 6.31% | 7.23% | 44.17% | 18.08% | |||
| PFE | PFIZER INC | $156.19B | $27.47 | $28.29 | 2.97% | Hold | 7 | -2.84% | 16.75% | 13.28% | 5.91% | |||
| BIIB | BIOGEN INC | $28.69B | $195.50 | $198.78 | 1.68% | Buy | 18 | -1.22% | 23.87% | 14.55% | 9.02% | |||
| NVS | NOVARTIS AG | $307.56B | $161.18 | $118.00 | -26.79% | Strong Sell | 1 | 3.81% | 15.02% | 47.88% | 19.91% | |||
| SCLX | SCILEX HOLDING CO | $62.66M | $8.26 | N/A | N/A | N/A | N/A | 170.24% | N/A | -46.93% | 30.57% | |||
| MIRA | MIRA PHARMACEUTICALS INC | $49.41M | $1.18 | N/A | N/A | N/A | N/A | N/A | N/A | -101.84% | -100.72% | |||
| MDCX | MEDICUS PHARMA LTD | $21.87M | $0.99 | $27.00 | 2,619.03% | Strong Buy | 1 | N/A | N/A | -2,616.99% | 238.71% | |||
| NSRX | NASUS PHARMA LTD | $50.46M | $5.60 | $20.50 | 266.07% | Strong Buy | 2 | N/A | N/A | N/A | -1,697.09% |